ArticleFrontiers in pharmacology2021

Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME.

Margarita L Martinez-Fierro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.